Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura

Acute thrombotic thrombocytopenic purpura (aTTP) is a rare microangiopathic hemolytic anemia. Standard of care currently includes plasma exchange and immunosuppressive agents, including glucocorticoids, vincristine, and rituximab. Even with these therapies, relapse occurs in 36% of patients, and mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsivalis, Katherine V., Thomas, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Prescriber's Corner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017799/
https://www.ncbi.nlm.nih.gov/pubmed/34109052
http://dx.doi.org/10.6004/jadpro.2021.12.2.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017799/
https://www.ncbi.nlm.nih.gov/pubmed/34109052
http://dx.doi.org/10.6004/jadpro.2021.12.2.8

Ejemplares similares